Hormel Foods Named a Best for Vets Employer for 13th Consecutive Year — Neutral
HRL PRNewsWire — November 17, 2025AUSTIN, Minn. , Nov. 17, 2025 /PRNewswire/ -- Hormel Foods Corporation, (NYSE: HRL), a Fortune 500 global branded food company, today announced it has once again been named on Military Times' 2025 Best for Vets employer list for the 13th consecutive year.
Lowe's Companies Is Still Fully Valued Ahead Of The Q3 Release — Negative
LOW Seeking Alpha — November 17, 2025Lowe's Companies, Inc. remains resilient with strong fundamentals and growing Pro segment exposure but faces inflationary headwinds and limited upside. LOW appears fully valued at current prices, with technicals showing bearish signals and downside price risks outweighing near-term upside potential. Robust liquidity, prudent debt management, and strategic geographic presence help LOW weather market challenges, but Home Depot offers better fundamentals and upside.
Fiverr: You're Still Early In This Under The Radar AI Winner — Positive
FVRR Seeking Alpha — November 17, 2025Fiverr (FVRR) is undergoing a strategic up-market shift, focusing on high-quality talent and larger business projects despite AI-driven disruption. FVRR delivered strong Q3 results, with 8% revenue growth, record operating margins, and robust free cash flow, and the stock only trades at 9x FCF. The platform's up-market tools and AI talent base are driving higher spend per buyer and rapid growth in managed services and tech categories.
How SoundHound's $269 Million Cash Pile Fuels AI Expansion — Positive
SOUN Zacks Investment Research — November 17, 2025SOUN's $269M cash stash is fueling bold AI moves, from new platforms to acquisitions and global enterprise expansion.
Why Broadcom Inc. (AVGO) is Poised to Beat Earnings Estimates Again — Positive
AVGO Zacks Investment Research — November 17, 2025Broadcom Inc. (AVGO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Bank of America plans to spend billions of dollars on technologies such as artificial intelligence to boost bankers' productivity and bring in more revenue, its chief technology and information officer said on Monday.
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies London Healthcare Conference 2025 Transcript — Neutral
REGN Seeking Alpha — November 17, 2025Regeneron Pharmaceuticals, Inc. ( REGN ) Jefferies London Healthcare Conference 2025 November 17, 2025 10:30 AM EST Company Participants Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis Christopher Fenimore - Executive VP of Finance & CFO Conference Call Participants Akash Tewari - Jefferies LLC, Research Division Presentation Akash Tewari Jefferies LLC, Research Division Thanks so much, everyone. It's funny.
Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript — Neutral
ELDN Seeking Alpha — November 17, 2025Eledon Pharmaceuticals, Inc. ( ELDN ) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 12, 2025 10:30 AM EST Company Participants Steven Perrin - President, Chief Scientific Officer & Non Independent Director Conference Call Participants Vamil Divan - Guggenheim Securities, LLC, Research Division Presentation Vamil Divan Guggenheim Securities, LLC, Research Division All right. Thanks, everyone, for joining us here on the Second Annual Guggenheim Healthcare Innovation Conference.
The market-wide AI-related correction has already triggered CRWV's cheaper valuation, with the expanding multi-year backlog sustaining its high-growth thesis. The recent project delays and the intensified capex cadence are likely to contribute to the neocloud's robust FY2026 top-line performance, despite the tougher YoY comparison. As a result of the 2Y+ time lag between the capex and revenue recognition, it is unsurprising that CRWD's balance sheet continues to deteriorate.
Disney: Questions Raised About Long-Term Recovery Of Its Stock — Positive
DIS Seeking Alpha — November 17, 2025Disney stock is now range-bound between $80 and $120, reflecting a new valuation reality for the legacy media giant. DIS faces challenges regaining its previous highs, especially with industry consolidation like potential media mergers complicating the competitive landscape. A major catalyst, such as splitting the parks/live business from media, could unlock higher valuation, but near-term breakthroughs are unlikely.
Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer — Positive
NUVL Benzinga — November 17, 2025Nuvalent, Inc. (NASDAQ: NUVL) on Monday reported topline results from its ALKOVE-1 Phase 1/2 trial.
Italy considers one-time 52% tax cut on private gold holdings — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — November 17, 2025Italy is considering a one-off levy for households to declare gold that is being held off the books – a move that could raise over 2 billion euros, or $2.3 billion, according to an amendment to the 2026 budget seen by Reuters.
Ford and Amazon just redefined the used-car marketplace — Positive
AMZN F Fast Company — November 17, 2025Beep, beep: Amazon is making a bigger move into the market for used vehicles. The retail giant and Ford Motor Company announced a partnership today which will mean car buyers in three major cities can shop for, finance, and purchase a certified preowned Ford vehicle on Amazon Autos.
Popular (BPOP) Upgraded to Strong Buy: Here's Why — Positive
BPOP Zacks Investment Research — November 17, 2025Popular (BPOP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Are You Looking for a Top Momentum Pick? Why Welltower (WELL) is a Great Choice — Positive
WELL Zacks Investment Research — November 17, 2025Does Welltower (WELL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Gain Therapeutics (GANX) Upgraded to Buy: Here's What You Should Know — Positive
GANX Zacks Investment Research — November 17, 2025Gain Therapeutics (GANX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Evertec (EVTC) Upgraded to Buy: Here's What You Should Know — Positive
EVTC Zacks Investment Research — November 17, 2025Evertec (EVTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What Makes Riskified (RSKD) a New Buy Stock — Positive
RSKD Zacks Investment Research — November 17, 2025Riskified (RSKD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Northrim (NRIM) Upgraded to Strong Buy: Here's Why — Positive
NRIM Zacks Investment Research — November 17, 2025Northrim (NRIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Arlo Technologies (ARLO) Upgraded to Strong Buy: Here's What You Should Know — Positive
ARLO Zacks Investment Research — November 17, 2025Arlo Technologies (ARLO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).